Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase I
Prothena Corporation plc Release: Initiation Of Multiple Ascending Dose Phase 1 Study Of PRX002 In Patients With Parkinson's Disease 8/1/2014 8:34:38 AM
M. D. Anderson Cancer Center Postdoc Faked Results Of Novartis AG (NVS) Brain Tumor Study 8/1/2014 6:55:14 AM
BioTime (BTX) Subsidiary OncoCyte Corporation Expands Clinical Development Of Bladder Cancer Diagnostic By Initiating A Large Multi-Site Clinical Trial 7/31/2014 10:56:29 AM
AFFiRiS AG Release: First Clinical Data Of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 7/31/2014 10:22:24 AM
Cara Therapeutics, Inc. (CARA) Initiates Human Abuse Liability Trial Of CR845 7/31/2014 10:21:54 AM
AFFiRiS AG Presents Phase I Data On A First-Of-Its-Kind Treatment With Support From The Michael J. Fox Foundation 7/31/2014 10:16:11 AM
AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY) 7/31/2014 7:47:00 AM
Galectin Therapeutics Issues Statement on GR-MD-02 Development Program 7/30/2014 10:49:19 AM
AtheroNova Inc. (AHRO.OB) Announces Milestone With Initiation Of Phase 1b Clinical Trial Of AHRO-001 7/30/2014 8:09:21 AM
Inergetics, Inc. Completes Phase I Development Of Its Therapeutic CBD Line Of Products 7/29/2014 8:20:18 AM
Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 7/28/2014 8:05:34 AM
Galectin Therapeutics To Host Webcast To Discuss Findings From Cohort 2 Of Phase 1 Clinical Trial Of GR-MD-02 In Fatty Liver Disease With Advanced Fibrosis 7/25/2014 8:00:03 AM
Amunix, Inc. And PolyPeptide Publish Multivalent Antiviral XTEN-Peptide Conjugates In Vivo Studies In American Chemical Society's Journal 7/24/2014 1:11:10 PM
Media Advisory: AFFiRiS AG Presents Early Clinical Data On A First-Of-Its-Kind Parkinson's Disease Vaccine 7/24/2014 11:00:49 AM
Advanced Biologics Publishes Additional OsteoampĀ® Abstracts In The Bone And Joint Journal 7/24/2014 10:04:16 AM
1234567
//-->